A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Running, not enrolling
Conditions studied: Geographic Atrophy
In brief
A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration
Key facts
- Study ID
- NCT06161584
- Run by
- Apellis Pharmaceuticals, Inc.
- People needed
- 300
- Starts
- 2023-09-28
- Expected to finish
- 2027-06-01
- Last updated by the study team
- 2026-06-01
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- California Retina Consultants (01-026) — Bakersfield, California, United States
- Retina-Vitreous Associates Medical Group (01-020) — Beverly Hills, California, United States
- Illinois Retina Associates (01-035) — Fullerton, California, United States
- Retinal Consultants Medical Group Inc (01-008) — Modesto, California, United States
- Retina Consultants San Diego Inc. (01-018) — Poway, California, United States
- California Retina Consultants (01-027) — Santa Barbara, California, United States
- Bay Area Retina Associates (01-005) — Walnut Creek, California, United States
- Colorado Retina Associates, PLLC (01-011) — Lakewood, Colorado, United States
- Retina Specialty Institute (01-019) — Pensacola, Florida, United States
- South East Retina Center, PC (01-030) — Augusta, Georgia, United States
- Georgia Retina (01-032) — Marietta, Georgia, United States
- Illinois Retina Associates (01-037) — Oak Park, Illinois, United States
- The Retina Care Center (01-023) — Baltimore, Maryland, United States
- Cumberland Valley Retina Consultants, P.C. (01-002) — Hagerstown, Maryland, United States
- Mid Atlantic Retina Specialist (01-029) — Hagerstown, Maryland, United States
- Retina Consultants of Minnesota, PLLC (01-025) — Edina, Minnesota, United States
- Mid Atlantic Retina Research (01-014) — Cherry Hill, New Jersey, United States
- Mid Atlantic Retina (01-031) — Cherry Hill, New Jersey, United States
- OCLI Research Department (01-007) — Oceanside, New York, United States
- Long Island Vitreoretinal Consultants (01-013) — Westbury, New York, United States
- Western Carolina Retinal Associates, PA (01-009) — Asheville, North Carolina, United States
- Retina Associates of Cleveland, Inc. (01-017) — Cleveland, Ohio, United States
- Retina Associates of Cleveland, Inc. (01-022) — Cleveland, Ohio, United States
- Retina Associates of Cleveland, Inc. (01-016) — Youngstown, Ohio, United States
- Mid Atlantic Retina (01-001) — Bethlehem, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.